Use of biological medicines in the treatment of autoimmune diseases: comparison of efficacy and costs
PDF (Português (Brasil))

Keywords

Câncer de Colo de Útero. Diagnóstico. Prevenção. HPV. Tecnologia.

How to Cite

Corduva, G., Rodrigues de Souza, A., da Silva Ramos, T. C., de Lima Souza, S., Lima de Brito, J. J., Diniz Legramanti, R. J., Carvalho Guedes, A. C., Peterle Bussolotti, B., Cassemiro, P., de Freitas Muniz, L., & Gomes Sousa, M. (2025). Use of biological medicines in the treatment of autoimmune diseases: comparison of efficacy and costs. Brazilian Journal of Implantology and Health Sciences, 7(3), 1487–1494. https://doi.org/10.36557/2674-8169.2025v7n3p1487-1494

Abstract

 This article details an examination of the cervical cancer epidemic, based on new diagnostic and prevention protocols. The central purpose of this research was to explore how recent advances in diagnostic technologies and prevention strategies can be effectively integrated into public health programs to reduce the incidence and mortality of cancer across various socioeconomic regions. To achieve this goal, the following specific objectives were defined: to assess the effectiveness of current screening methods, compare the immune response before and after HPV vaccination, analyze the socioeconomic impact of the strategies, and examine the feasibility of integrating new technologies into public health systems. The methodological approach adopted included a review of relevant literature and the analysis of secondary data. The research findings showed that the new protocols are improving cancer detection and prevention, leading to the conclusion that these strategies are crucial for effectively combating the disease on a global scale. The final observations highlight the need to continue investigations in this area to deepen the understanding of the subject and promote future advancements.

https://doi.org/10.36557/2674-8169.2025v7n3p1487-1494
PDF (Português (Brasil))

References

SHAO, R.; LI, F.; CHEN, Z. *Efficacy of HPV vaccination in preventing cervical cancer: A systematic review*. *Journal of Clinical Oncology*, v. 41, n. 4, p. 345-357, 2023. Disponível em: https://doi.org/10.1200/JCO.22.01569. Acesso em: 22 jan. 2025.

KYRGIOU, M.; KOLIOPOULOS, G.; ARBYN, M. *Human papillomavirus testing for cervical cancer screening: Current perspectives and future directions*. *The Lancet Oncology*, v. 23, n. 1, p. 78-89, 2022. Disponível em: https://doi.org/10.1016/S1470-2045(21)00456-3. Acesso em: 22 jan. 2025.

CUZICK, J.; CLAVEL, C.; PETRY, K. U. *Molecular markers and HPV testing in cervical cancer screening: A comprehensive review*. *European Journal of Cancer Prevention*, v. 30, n. 2, p. 94-104, 2021. Disponível em: https://doi.org/10.1097/CEJ.0000000000000573. Acesso em: 22 jan. 2025.

BRUNI, L.; ALBERO, G.; SERRANO, B. *Global impact of human papillomavirus vaccination on cervical cancer incidence and mortality: A systematic review*. *Vaccine*, v. 40, n. 1, p. 5-14, 2022. Disponível em: https://doi.org/10.1016/j.vaccine.2021.11.051. Acesso em: 22 jan. 2025.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Gabriely Corduva, Anaile Rodrigues de Souza, Thauana Carolina da Silva Ramos, Sheila de Lima Souza, Jean Jacques Lima de Brito, Roque Júnior Diniz Legramanti, Aline Cristina Carvalho Guedes, Bruno Peterle Bussolotti, Polyane Cassemiro, Leandrius de Freitas Muniz, Matias Gomes Sousa

Downloads

Download data is not yet available.